Présentations
Coltin H, Brundler MA, Ulster A, Griffiths B, Milne M, Venier R. Meet the Experts Panel, Canadian Retinoblastoma Research Advisory Board Research Symposium, Toronto, ON, 2023
Coltin H. Long-term outcomes of pediatric central nervous system tumour survivors, Pediatric Ontario Group of Ontario Multi-Disciplinary Symposium on Childhood Cancer, Toronto, ON, 2022 (invited keynote speaker)
Coltin H. Long-term outcomes of pediatric central nervous system tumour survivors, CHU Sainte-Justine Research Centre Scientific Conference, Montreal, QC, 2022
Coltin H. A health services research approach to study the long-term outcomes of pediatric medulloblastoma and ependymoma survivors, Hospital for Sick Children Haematology/Oncology Divisional Rounds, Toronto, ON, 2022
Coltin H. Subgroup and subtype specific outcomes in adult medulloblastoma, Garron Family Cancer Centre Virtual Cancer Research Week, Toronto, ON, 2021
Publications
Coltin H, Pequeno P, Liu N, et al. The Burden of Surviving Childhood Medulloblastoma: A Population-Based, Matched Cohort Study in Ontario, Canada [published online ahead of print, 2023 Jan 25]. J Clin Oncol. 2023; JCO2202466. doi:10.1200/JCO.22.02466
Arbour G, Ellezam B, Weil AG, Cayrol R, Vanan MI, Coltin H, Larouche V, Erker C, Jabado N, Perreault S. Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature. Neurooncol Adv. 2022 Nov 19;4(1): vdac174. doi: 10.1093/noajnl/vdac174
Coltin H, Perreault S, Larouche V, et al. Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real-world case series. Pediatr Blood Cancer. 2022;69(8): e29633. doi:10.1002/pbc.29633
Coltin H, Ramaswamy V. Molecular and clinical correlates of medulloblastoma subgroups: A narrative review. Glioma 2021; 4:92-9. DOI: 10.4103/glioma.glioma_18_21
Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, Armstrong L, Blood KA, Brossard J, Brunga L, Cacciotti C, Caswell K, Cellot S, Clark ME, Clinton C, Coltin H, Felton K, Fernandez CV, Fleming AJ, Fuentes-Bolanos N, Gibson P, Grant R, Hammad R, Harrison LW, Irwin MS, Johnston DL, Kane S, Lafay-Cousin L, Lara-Corrales I, Larouche V, Mathews N, Meyn MS, Michaeli O, Perrier R, Pike M, Punnett A, Ramaswamy V, Say J, Somers G, Tabori U, Thibodeau ML, Toupin AK, Tucker KM, van Engelen K, Vairy S, Waespe N, Warby M, Wasserman JD, Whitlock JA, Sinnett D, Jabado N, Nathan PC, Shlien A, Kamihara J, Deyell RJ, Ziegler DS, Nichols KE, Dendukuri N, Malkin D, Villani A, Foulkes WD. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncol. 2021 Dec 1;7(12):1806-1814. doi: 10.1001/jamaoncol.2021.4536
Coltin H, Rapoport A, Baxter NN, et al. Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: A population-based study using the IMPACT cohort. Cancer. 2022;128(2):326-334. doi:10.1002/cncr.33926
Coltin H, Sundaresan L, Smith KS, et al. Subgroup and subtype-specific outcomes in adult medulloblastoma. Acta Neuropathol. 2021;142(5):859-871. doi:10.1007/s00401-021-02358-4
Baroni LV, Sundaresan L, Heled A, Coltin H, Pajtler KW, Lin T, Merchant TE, McLendon R, Faria C, Buntine M, White CL, Pfister SM, Gilbert MR, Armstrong TS, Bouffet E, Kumar S, Taylor MD, Aldape KD, Ellison DW, Gottardo NG, Kool M, Korshunov A, Hansford JR, Ramaswamy V. Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q. Neuro Oncol. 2021 Aug 2;23(8):1360-1370. doi: 10.1093/neuonc/noab034
Bennett J, Erker C, Lafay-Cousin L, Ramaswamy V, Hukin J, Vanan MI, Cheng S, Coltin H, Fonseca A, Johnston D, Lo A, Zelcer S, Alvi S, Bowes L, Brossard J, Charlebois J, Eisenstat D, Felton K, Fleming A, Jabado N, Larouche V, Legault G, Mpofu C, Perreault S, Silva M, Sinha R, Strother D, Tsang DS, Wilson B, Crooks B, Bartels U. Canadian Pediatric Neuro-Oncology Standards of Practice. Front Oncol. 2020 Dec 22;10:593192. doi: 10.3389/fonc.2020.593192
Paquette K, Coltin H, Boivin A, Amre D, Nuyt AM, Luu TM. Cancer risk in children and young adults born preterm: A systematic review and meta-analysis. PLoS One. 2019;14(1):e0210366. Published 2019 Jan 4. doi:10.1371/ journal.pone.0210366